Ceribell (CBLL) Stock Looks Stretched Despite New AI Monitoring Launch
CeriBell (CBLL) Climbed, What Is Behind The Fresh Attention?
Ceribell (CBLL) Stock Gets Fair Value Bump As Analysts Back Rapid EEG Growth
How Raised Revenue Guidance At CeriBell (CBLL) Has Changed Its Investment Story
Canaccord Genuity Maintains Buy on CeriBell, Raises Price Target to $33
CeriBell (CBLL) Q3 2026 Earnings Call Transcript
CeriBell, Inc. Q3 2026 Earnings Call Summary
CeriBell Inc (CBLL) (Q3 2026) Earnings Call Highlights: Record Hospital Additions and 30% ...
CeriBell Q3 Earnings Call Highlights
CeriBell, Inc. (CBLL) Reports Q3 Loss, Tops Revenue Estimates
Ceribell (NASDAQ:CBLL) Falls After In-Line Q3 Revenue and Guidance Below Consensus
Compared to Estimates, CeriBell, Inc. (CBLL) Q3 Earnings: A Look at Key Metrics
Ceribell Reports Third Quarter 2026 Financial Results
CeriBell, Inc. (CBLL) Q3 2026 Earnings Call Transcript
CeriBell Q3 2026 Earnings Call Transcript
CeriBell Raises FY2026 Sales Guidance from $114.000M-$117.000M to $115.000M-$117.000M vs $115.537M Est
CeriBell Q3 EPS $(0.55) Misses $(0.51) Estimate, Sales $29.341M Beat $29.164M Estimate
Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
Is CeriBell (CBLL) Fully Priced After A 133% One Year Run?
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.